Publication | Closed Access

Antinociceptive effects of the non-selective cannabinoid receptor agonist CP 55,940 are absent in CB1−/− and not CB2−/− mice in models of acute and persistent pain

Pain DisordersPain MedicineNeuropathic PainMolecular PainPharmacotherapyCannabinoid PharmacologyMolecular PharmacologyPain ManagementAntinociceptive EffectsHealth SciencesCannabis UseNeuropharmacologyPharmacologyPain ResearchCb2−/− MicePersistent PainNeurosciencePain MechanismMedicine